An alginate‐based biochar hydrogel (ABC‐hydrogel), derived from sewage sludge, is developed for simultaneous phosphate removal and agricultural reuse. It captures phosphorus from water and gradually releases it as fertilizer, enhancing lettuce growth.
Yu Zhang+4 more
wiley +1 more source
Specificity of Food and Drug Administration postmarketing requirements and associations with timely submissions and regulatory decisions for oncology accelerated approvals, 2011-2023: a cross-sectional analysis. [PDF]
Kurian M+7 more
europepmc +1 more source
An innovative fabrication platform for 3D microelectrode arrays (MEAs) is presented, utilizing a 3D printer and the capillary action of electrically conductive inks. This approach enables the simple and versatile fabrication of 3D MEAs with complex structures.
Dongjo Yoon, Yoonkey Nam
wiley +1 more source
Abemaciclib-associated kidney injuries: A retrospective analysis of the United States Food and Drug Administration adverse events reporting system. [PDF]
Xu X+7 more
europepmc +1 more source
Photoresponsive Gas‐Permeable Membranes: Fundamentals, Innovations, and Prospects
Photoresponsive gas‐permeable membranes can be potentially used for smart packing, carbon capture, hydrogen purification, and optical gas valves due to their remote and non‐contact activation, precise spatial and temporal control, and reversible switching capabilities.
Zhuan Wang+6 more
wiley +1 more source
Impact of Global Enrollment on Race, Ethnicity, and Age Representation in Pivotal Gynecologic Cancer Trials Leading to US Food and Drug Administration Drug Approvals. [PDF]
Khan MH+6 more
europepmc +1 more source
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz+3 more
wiley +1 more source
Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023. [PDF]
Martins AC+3 more
europepmc +1 more source
United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy [PDF]
Robert C. Kane+3 more
openalex +1 more source